Возраст домена | 18 лет |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | |
Страниц в Google | 8 |
Страниц в Яндексе | 9 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 8814669 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Investing in the future of medicine ~ Omega Funds
n/a
Bringing science to patients, Omega Funds have helped bring 37 products to market. People. Products. Platforms.
UTF-8
145.7 КБ
1 065
8 737 симв.
7 419 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() |
3 | n/a | 0 | 11010988 | ![]() |
|
![]() ![]() |
2 | 9 |
0 | 9 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 927 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 5214 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 7787 | ![]() | |
![]() ![]() |
2 | 9 |
0 | 25 | ![]() | |
![]() |
2 | 8 |
0 | 516471 | ![]() | |
![]() |
2 | 4 |
0 | 428314 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 201 | ![]() | |
![]() ![]() |
2 | 9 |
0 | 5 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 12 Июня 2017 ) | |
Количество ссылок на сайт | 58 |
Количество доменов, которые ссылаются на сайт | 19 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 24 |
Количество доменов, на которые ссылается сайт | 24 |
Количество исходящих анкоров | 1 |
Внешние ссылки главной страницы ( 62 ) | |
s3.amazonaws.com/omegafunds.net/wp-content/uploads/2019/12/O... | Download PDF |
sscfundservices.com/login.aspx | Investor Portal |
linkedin.com/company/22284526/ | |
linkedin.com/in/richard-lim-14a16a5/ | |
linkedin.com/in/claudio-nessi-8112569/ | |
linkedin.com/in/anne-mari-paster-4a388211/ | |
linkedin.com/in/otello-stampacchia-82aa5a19/ | |
linkedin.com/in/dina-chaya-00253a13/ | |
linkedin.com/in/michelle-doig-934ba88/ | |
linkedin.com/in/francescodraetta/ | |
linkedin.com/in/thomas-goebel-607a681/ | |
linkedin.com/in/paulinahill/ | |
linkedin.com/in/katiekerfoot/ | |
linkedin.com/in/annie-mitsak-666b72a/ | |
linkedin.com/in/vincent-ossipow-b2a80b89/ | |
linkedin.com/in/philippbliedung/ | |
linkedin.com/in/gilchrist-diprete-73441023/ | |
linkedin.com/in/markerusselljr/ | |
linkedin.com/in/deirdre-cunnane-413ba92/ | |
linkedin.com/in/pennylynncanto/ | |
linkedin.com/in/ellissa-stanley-633247141/ | |
linkedin.com/in/estelle-decosterd-475b9543/?originalSubdomai... | |
linkedin.com/in/caroline-napoli-a1b2c/ | |
linkedin.com/in/hbrady721/ | |
linkedin.com/in/mcdermottcharles/ | |
ampyra.com/ | Ampyra: Extended release, oral ion-channel blocker to improve walking in Multiple Sclerosis patients. |
fda.gov/drugs/drug-safety-and-availability/impact-exclusivit... | ArymoER: Opioid agonist for the management of severe pain. |
lilly.com/products/historic-products | Axiron: Topical testosterone for treating males with low or no testosterone. |
baxdela.com/ | Baxdela: Antibiotic to treat acute bacterial skin and skin structure infections (ABSSSI) in both intravenous (IV) and oral formu... |
bidil.com/ | BiDil: Indicated for use with other heart medicines to treat heart failure in African American patients. |
blincyto.com/ | Blincyto: First bi-specific antibody for the treatment of acute lymphoblastic leukemia. |
firazyr.com/ | Firazyr: Injectable bradykinin receptor antagonist for the treatment of acute hereditary angioedema. |
imlygic.com/ | Imlygic: The first oncolytic viral therapy for the local treatment of recurrent melanoma. |
adlyxin.com/ | Lyxumia: Subcutaneously administered GLP-1 agonist for type 2 diabetes. |
nuzyra.com/ | Nuzyra: The first once-daily antibiotic to treat CABP and ABSSSI that is available in both an intravenous (IV) and oral formulat... |
oxaydo.com/ | Oxaydo: Immediate-release, oral oxycodone HCl for acute and chronic pain. |
fibrogen.com/roxadustat/ | Roxadustat: First-in-class, oral drug for the treatment of anemia in chronic kidney disease patients on dialysis. |
ema.europa.eu/en/medicines/human/EPAR/selincro | Selincro: An oral opioid receptor ligand for treating alcohol dependence. |
seysara-hcp.com | Seysara: Tetracycline-derived antibiotic for the treatment of moderate to severe acne vulgaris. |
sprix.com/ | Sprix: Novel nasal spray formulation of an NSAID for pain management. |
soseiheptares.com/our-medicines/our-medicines-2/eurow.html | Ultibro: Inhalable bronchodilator treatment for chronic obstructive pulmonary disease. |
rxabbvie.com/ | Viekira Pak: Extended-release tablets for treating chronic hepatitis C virus infection. |
xadago.com/ | Xadago: Used with levodopa to control motor fluctuations in Parkinson’s disease patients. |
xenazineusa.com/ | Xenazine: Indicated for treating chorea associated with Huntington’s disease. |
xenleta.com/ | Xenleta: First IV and oral antibiotic with a novel mechanism of action approved by the FDA in nearly two decades. Treats communi... |
zemdri.com/ | Zemdri: An antibiotic indicated for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis. |
andrewalliance.com/single-channel-pipetting-robot/ | Andrew: The liquid handling robot designed to enhance the reproducibility and efficiency of the pipetting process. |
andrewalliance.com/pipetting-robot/ | Andrew+: The second generation liquid handling robot, can perform a wide range of complex experimental steps. |
andrewalliance.com/laboratory-software/ | One-Lab: Cloud-based intelligent laboratory software to design and execute liquid handling protocols. |
thermofisher.com/us/en/home/life-science/pcr/real-time-pcr/r... | OpenArray: High-throughput system for PCR-based genotyping, gene expression, and microRNA analysis. |
andrewalliance.com/electronic-pipettes/ | Pipette+: The first connected smart pipetting system for maximum experiment repeatability with the minimum of effort. |
sophion.com/products/qube/ | Sophion Qube: A high throughput system for ion channel screening. |
medtronic.com/us-en/healthcare-professionals/products/cardia... | CryoConsole: Cardiac Cryoablation System for treating paroxysmal atrial fibrillation. |
hydrocision.com/hydro/products/spineJet.shtml | SpineJet: Hydrosurgery system for minimally invasive spine surgery. |
product-finder.basf.com/group/corporate/product-finder/en/br... | Cultivance: Weed control solution containing genetically modified soybean plants and tailor made herbicides. |
epiprocolon.com/us | Epi ProColon: The first blood test for colorectal cancer screening. |
epiprolung.com/en/ | Epi ProLung: Assay for detection of mSHOX2 in patients suspected of having lung cancer. |
magnetosbonegraft.com/ | MagnetOs: Indicated for use as an osteoconductive and osteoinductive bone void filler in the skeletal system. |
agendia.com/our-tests/mammaprint/ | Mammaprint: A diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other... |
kuros.ch/surgical-sealants/ | Neuroseal: A synthetic tissue sealant candidate for the prevention of CSF leakage following cranial or spinal surgery. |
scibase.com/the-nevisense-product/ | Nevisense: The world’s first objective diagnostic support tool for non-visual detection of malignant melanoma. |
impression.studio | Impression |
Внутренние ссылки главной страницы ( 1 ) | |
#top | Omega Funds |
Domain Name: OMEGAFUNDS.NET
Registry Domain ID: 369030114_DOMAIN_NET-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucowsdomains.com
Updated Date: 2018-02-08T05:14:40Z
Creation Date: 2006-03-09T13:48:54Z
Registry Expiry Date: 2019-03-09T12:48:54Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: CERES.2E2GSY.NET
Name Server: MERCURY.XKOGSY.NET
Name Server: VENUS.XKOGSY.NET
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-12T07:27:48Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
# Default Flywheel robots file
User-agent: *
Allow: /*?v
Disallow: /calendar/action*
Disallow: /events/action*
Disallow: /*?
Crawl-delay: 3
США - 208.80.152.201
Wikimedia Foundation
Wikimedia Foundation
HTTP/1.1 200 OK
Date: Sun, 29 Dec 2019 22:35:15 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 149196
Connection: keep-alive
Vary: Accept-Encoding
Vary: Accept-Encoding
Set-Cookie: PHPSESSID=8170431867134b07c9871eefdf855056; path=/
Pragma: no-cache
Link: ; rel="https://api.w.org/"
Link: ; rel=shortlink
X-FW-Server: Flywheel/4.1.0
X-FW-Hash: 983d4wpy2q
Server: Flywheel/4.1.0
Cache-Control: no-store, no-cache, must-revalidate
X-Cacheable: NO:Not Cacheable
X-FW-Serve: TRUE
X-Cache: MISS
X-FW-Static: NO
X-FW-Type: FLYWHEEL_BOT
Accept-Ranges: bytes
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"